As the reporting season draws to a close, it's understandable if you're holding your breath as some companies delay releasing potentially lacklustre results.' While not every report can be a winner, we believe the last few weeks had two further standout performers in...
Earnings season is well and truly underway with a number of companies in the TAMIM portfolio reporting last week. Two stand out and high conviction holdings that reported were Bravura Solutions Limited (ASX: BVS) and Viva Leisure (ASX: VVA). Coincidently we recently...
The market continues to present opportunities for the strategic investor ahead of the upcoming earnings season. Amidst recent volatility, the small-cap space remains a fertile ground for potential, as demonstrated by the latest developments in the TAMIM Australian...
Healthcare companies are often seen as defensive investments during volatile times due to the non-discretionary nature of the majority of the industry's spend. Beyond this inherent defensiveness, the sector also offers pockets of growth, particularly for companies...
Healthcare accounts for approximately 10% of the S&P/ASX 200 index and is widely regarded as a reliable and defensive sector that provides returns that are relatively uncorrelated with the rest of an investor’s portfolio and the economy at large–often with less...
Volpara Health Technologies Receives Premium Offer from Lunit Inc 21/12/2023 Volpara Health Technologies (ASX: VHT) shares rocketed 41% on last Thursday to $1.10 following a takeover offer from Lunit Inc for $1.15 per share. Lunit, recognising the potential of Volpara...
Healthia Soars on Takeover Bid 7/9/2023 Shares in allied healthcare company Healthia (ASX: HLA) rocketed higher last Thursday when it announced the company had received a takeover bid from private equity company Pacific Equity Partners. Private equity companies...
This week Ron Shamgar takes a look at an expanding healthcare services company that has traded well despite a tough operating period; a stock that could also potentially be interesting from an M&A perspective. Monash IVF Group (MVF.ASX) MVF is a leader in the...
With reporting season now over, investors can take the time to review the results. Stocks will often take time to rerate after the release of a good result as they can get lost amongst hundreds of others. This week we will talk about IGL’s results and why we believe...
This week we will continue looking at reporting season with a look at two companies that saw challenging trading conditions in the half as a result of Covid-19 impacts and explain why their outlook for FY22 is strong. Many companies saw tougher trading conditions but...
This week the Small Cap team review their investment in Zenitas Healthcare Limited (ZNT.ASX). Zenitas Healthcare Limited (ZNT.ASX – formerly BGD.ASX) is a community healthcare company providing a range of community-based health services - allied care, home care &...
